The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Karnofsky performance status revisited: reliability, validity, and guidelines.
Abstract
Little research has been conducted documenting the reliability and validity of the Karnofsky Performance Status (KPS) scale, and guidelines based on empirical data do not exist to govern its use. Two hundred ninety-three cancer patients completed a questionnaire that assesses their physical and psychosocial difficulties. Physicians rated patients on the KPS and a subsample of 75 patients was used to evaluate interrater reliability. Analyses were conducted to evaluate the interrater reliability and construct validity of the KPS. The KPS was shown to have good reliability and validity. Detailed examination of the reliability data suggested areas in which physicians err in their judgments. Multiple regression techniques were used to empirically identify seven behaviorally based questions that would be helpful in predicting KPS scores. The seven variables included weight loss, weight gain, reduced energy, difficulty walking, driving, grooming, and working part time. An interview approach with behaviorally based guidelines is presented using these variables to obtain relevant data and make more accurate KPS ratings. With the approach suggested and the guidelines presented, oncologists may train themselves to use the KPS in a standard way, which should increase reliability and validity of the KPS and has implications for patients and research studies that use KPS as a stratifying variable.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Coefficient of Agreement for Nominal Scales
Cohen, J. (1960) · Educational and Psychological Measurement · doi:10.1177/001316446002000104 · Cited by 42,398
The clinical evaluation of chemotherapeutic agents in cancer
Karnofsky, D. A. (1949) · Medical Entomology and Zoology · Cited by 2,933
Evaluation of patients with advanced cancer using the karnofsky performance status
Yates, J. W., Chalmer, B., & McKegney, F. P. (1980) · Cancer · doi:10.1002/1097-0142(19800415)45:8<2220::aid-cncr2820450835>3.0.co;2-q · Cited by 898
Prognostic Factors for Survival in Patients With Inoperable Lung Cancer 2
(1980) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/65.1.25 · Cited by 564
Scientific problems in clinical scales, as demonstrated in the karnofsky index of performance status
Hutchinson, T. A., Boyd, N. F., & Feinstein, A. R. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90096-1 · Cited by 238
Living with cancer: The cancer inventory of problem situations
Heinrich, R. L., Schag, C. C., & Ganz, P. A. (1984) · Journal of Clinical Psychology · doi:10.1002/1097-4679(198407)40:4<972::aid-jclp2270400417>3.0.co;2-w · Cited by 125
Self-citationTannock, I. F., & Murphy, K. (1983) · Journal of Clinical Oncology · doi:10.1200/jco.1983.1.1.66 · Cited by 45
Cited by
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
Motzer, R. J., Escudier, B., McDermott, D. F., George, S., Hammers, H. J., Srinivas, S., Tykodi, S. S., Sosman, J. A., Procopio, G., Plimack, E. R., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510665 · Cited by 5,807
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
Motzer, R. J., Tannir, N. M., McDermott, D. F., Arén Frontera, O., Melichar, B., Choueiri, T. K., Plimack, E. R., Barthélémy, P., Porta, C., George, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1712126 · Cited by 4,656
“Hypertension 12 (2) 4 (<1) 216 (40) 85 (16)”
BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
Reig, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., Kelley, R. K., Galle, P. R., Mazzaferro, V., Salem, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.018 · Cited by 4,319
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma
Rini, B. I., Plimack, E. R., Stus, V., Gafanov, R., Hawkins, R., Nosov, D., Pouliot, F., Alekseev, B., Soulières, D., Melichar, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1816714 · Cited by 3,403
Aaronson, N. K., Muller, M., Cohen, P. D. A., Essink-Bot, M.-L., Fekkes, M., Sanderman, R., Sprangers, M. A. G., te Velde, A., & Verrips, E. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00097-3 · Cited by 2,276
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Choueiri, T. K., Powles, T., Burotto, M., Escudier, B., Bourlon, M. T., Zurawski, B., Oyervides Juárez, V. M., Hsieh, J. J., Basso, U., Shah, A. Y., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2026982 · Cited by 1,791
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
Motzer, R., Alekseev, B., Rha, S.-Y., Porta, C., Eto, M., Powles, T., Grünwald, V., Hutson, T. E., Kopyltsov, E., Méndez-Vidal, M. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035716 · Cited by 1,766
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Fanta, P., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0008 · Cited by 1,684
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Sprangers, M. A., Groenvold, M., Arraras, J. I., Franklin, J., te Velde, A., Muller, M., Franzini, L., Williams, A., de Haes, H. C., Hopwood, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.10.2756 · Cited by 1,220
Sprangers, M. A. G., & Aaronson, N. K. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90052-o · Cited by 1,081
PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma
Gopal, A. K., Kahl, B. S., de Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., Flinn, I. W., Flowers, C. R., Martin, P., Viardot, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314583 · Cited by 1,069
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Chao, J., Corvera, C., Das, P., Denlinger, C. S., Enzinger, P. C., Fanta, P., Farjah, F., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0033 · Cited by 1,059
Azzoli, C. G., Baker, S., Temin, S., Pao, W., Aliff, T., Brahmer, J., Johnson, D. H., Laskin, J. L., Masters, G., Milton, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5622 · Cited by 915
Multicenter Phase II Study of Capecitabine in Paclitaxel-Refractory Metastatic Breast Cancer
Blum, J. L., Jones, S. E., Buzdar, A. U., LoRusso, P. M., Kuter, I., Vogel, C., Osterwalder, B., Burger, H.-U., Brown, C. S., & Griffin, T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.485 · Cited by 783
Powles, T., Plimack, E. R., Soulières, D., Waddell, T., Stus, V., Gafanov, R., Nosov, D., Pouliot, F., Melichar, B., Vynnychenko, I., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30436-8 · Cited by 751
Assessment of quality of life in head and neck cancer patients
Hassan, S. J., & Weymuller, E. A. (1993) · Head & Neck · doi:10.1002/hed.2880150603 · Cited by 659
Buccheri, G., Ferrigno, D., & Tamburini, M. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00664-8 · Cited by 629
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Cooke, D., Corvera, C., Das, P., Enzinger, P. C., Enzler, T., Farjah, F., Gerdes, H., et al. (2023) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2023.0019 · Cited by 569
Sprangers, M. A. G., te Velde, A., & Aaronson, N. K. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00357-8 · Cited by 506
Hammers, H. J., Plimack, E. R., Infante, J. R., Rini, B. I., McDermott, D. F., Lewis, L. D., Voss, M. H., Sharma, P., Pal, S. K., Razak, A. R. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.72.1985 · Cited by 505
Performance status assessment in cancer patients. An inter-observer variability study
Sørensen, J., Klee, M., Palshof, T., & Hansen, H. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.140 · Cited by 483
Péus, D., Newcomb, N., & Hofer, S. (2013) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-13-72 · Cited by 440
Effect of computer support on younger women with breast cancer
Gustafson, D. H., Hawkins, R., Pingree, S., McTavish, F., Arora, N. K., Mendenhall, J., Cella, D. F., Serlin, R. C., Apantaku, F. M., Stewart, J., et al. (2001) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2001.016007435.x · Cited by 387
Loprinzi, C. L., Laurie, J. A., Wieand, H. S., Krook, J. E., Novotny, P. J., Kugler, J. W., Bartel, J., Law, M., Bateman, M., & Klatt, N. E. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.3.601 · Cited by 384
Neuwelt, E. A., Goldman, D. L., Dahlborg, S. A., Crossen, J., Ramsey, F., Roman-Goldstein, S., Braziel, R., & Dana, B. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.9.1580 · Cited by 380
Weiner, H. L., Wisoff, J. H., Rosenberg, M. E., Kupersmith, M. J., Cohen, H., Zagzag, D., Shiminski-Maher, T., Flamm, E. S., Epstein, F. J., & Miller, D. C. (1994) · Neurosurgery · doi:10.1227/00006123-199412000-00001 · Cited by 373
Cancer cachexia and its pathophysiology: links with sarcopenia, anorexia and asthenia
Peixoto da Silva, S., Santos, J. M. O., Costa e Silva, M. P., Gil da Costa, R. M., & Medeiros, R. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12528 · Cited by 371
Keles, G. E., Anderson, B., & Berger, M. S. (1999) · Surgical Neurology · doi:10.1016/s0090-3019(99)00103-2 · Cited by 366
Schag, C. A. C., Ganz, P. A., & Heinrich, R. L. (1991) · Cancer · doi:10.1002/1097-0142(19910915)68:6<1406::aid-cncr2820680638>3.0.co;2-2 · Cited by 363
Self-citationCui, Y., Zhang, X.-P., Sun, Y.-S., Tang, L., & Shen, L. (2008) · Radiology · doi:10.1148/radiol.2483071407 · Cited by 361
Locatelli, F., Zugmaier, G., Rizzari, C., Morris, J. D., Gruhn, B., Klingebiel, T., Parasole, R., Linderkamp, C., Flotho, C., Petit, A., et al. (2021) · JAMA · doi:10.1001/jama.2021.0987 · Cited by 348
Northouse, L., Kershaw, T., Mood, D., & Schafenacker, A. (2005) · Psycho-Oncology · doi:10.1002/pon.871 · Cited by 338
Lightdale, C. J., Heier, S. K., Marcon, N. E., McCaughan, J. S., Gerdes, H., Overholt, B. F., Sivak, M. V., Stiegmann, G. V., & Nava, H. R. (1995) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(95)70002-1 · Cited by 341
Esophageal and Esophagogastric Junction Cancers
Ajani, J. A., Barthel, J. S., Bentrem, D. J., D'Amico, T. A., Das, P., Denlinger, C. S., Fuchs, C. S., Gerdes, H., Glasgow, R. E., Hayman, J. A., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0072 · Cited by 331
Ganz, P. A., Anne Schag, C. C., Lee, J. J., Polinsky, M. L., & Tan, S.-J. (1992) · Cancer · doi:10.1002/1097-0142(19920401)69:7<1729::aid-cncr2820690714>3.0.co;2-d · Cited by 330
Self-citationQuality of life in adult survivors of lung, colon and prostate cancer
Schag, C. A. C., Ganz, P. A., Wing, D. S., Sim, M. S., & Lee, J. J. (1994) · Quality of Life Research · doi:10.1007/bf00435256 · Cited by 329
Self-citationMeasuring quality of life in stroke.
de Haan, R., Aaronson, N., Limburg, M., Hewer, R. L., & van Crevel, H. (1993) · Stroke · doi:10.1161/01.str.24.2.320 · Cited by 321
Interpreting clinically significant changes in patient‐reported outcomes
Ringash, J., O'Sullivan, B., Bezjak, A., & Redelmeier, D. A. (2007) · Cancer · doi:10.1002/cncr.22799 · Cited by 305
Cavaletti, G., Cornblath, D. R., Merkies, I. S. J., Postma, T. J., Rossi, E., Frigeni, B., Alberti, P., Bruna, J., Velasco, R., Argyriou, A. A., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds329 · Cited by 293
The undertreatment of pain in ambulatory AIDS patients
Breitbart, W., Rosenfeld, B. D., Passik, S. D., McDonald, M. V., Thaler, H., & Portenoy, R. K. (1996) · Pain · doi:10.1016/0304-3959(95)00217-0 · Cited by 293
Telch, C. F., & Telch, M. J. (1986) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.54.6.802 · Cited by 289
Symptoms in Adults with Lung Cancer
Cooley, M. E. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(99)00150-5 · Cited by 288
Stewart, C. L., Warner, S., Ito, K., Raoof, M., Wu, G. X., Kessler, J., Kim, J. Y., & Fong, Y. (2018) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2018.08.004 · Cited by 287
Schmidt, M., Pfetzer, N., Schwab, M., Strauss, I., & Kämmerer, U. (2011) · Nutrition & Metabolism · doi:10.1186/1743-7075-8-54 · Cited by 265
McNeely, M. L., Parliament, M. B., Seikaly, H., Jha, N., Magee, D. J., Haykowsky, M. J., & Courneya, K. S. (2008) · Cancer · doi:10.1002/cncr.23536 · Cited by 229
“537 Oral/oropharynx 32 (62) 16 (64) 16 (59) Larynx/hypopharynx 12 (23) 6 (24) 6 (22) Thyroid 2 (4) 1 (4) 1 (4) Other* 6 (12) 2 (8) 4 (15) Disease stage .”
Pain in ambulatory AIDS patients. I: pain characteristics and medical correlates
Breitbart, W., McDonald, M. V., Rosenfeld, B., Passik, S. D., Hewitt, D., Thaler, H., & Portenoy, R. K. (1996) · Pain · doi:10.1016/s0304-3959(96)03215-0 · Cited by 204
Anxiety disorders in advanced cancer patients: Correlates and predictors of end‐of‐life outcomes
Spencer, R., Nilsson, M., Wright, A., Pirl, W., & Prigerson, H. (2010) · Cancer · doi:10.1002/cncr.24954 · Cited by 124
Mortality in Relation to Frailty in Patients Admitted to a Specialized Geriatric Intensive Care Unit
Zeng, A., Song, X., Dong, J., Mitnitski, A., Liu, J., Guo, Z., & Rockwood, K. (2015) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glv084 · Cited by 96
The multidimensional burden of informal caregivers in primary malignant brain tumor
Bayen, E., Laigle-Donadey, F., Prouté, M., Hoang-Xuan, K., Joël, M.-E., & Delattre, J.-Y. (2017) · Supportive Care in Cancer · doi:10.1007/s00520-016-3397-6 · Cited by 82
Henry, M., Rosberger, Z., Bertrand, L., Klassen, C., Hier, M., Zeitouni, A., Kost, K., Mlynarek, A., Richardson, K., Black, M., et al. (2018) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599818776873 · Cited by 76
Positive affect and suicide ideation in older adult primary care patients.
Hirsch, J. K., Duberstein, P. R., Chapman, B., & Lyness, J. M. (2007) · Psychology and Aging · doi:10.1037/0882-7974.22.2.380 · Cited by 68
Speight, J., Reaney, M. D., Woodcock, A. J., Smith, R. M., & Shaw, J. A. M. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03029.x · Cited by 64
Patient-reported physical activity questionnaires: a systematic review of content and format
Williams, K., Frei, A., Vetsch, A., Dobbels, F., Puhan, M. A., & Rüdell, K. (2012) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-10-28 · Cited by 52
Cohen, A., Ianovski, L. E., Frenkiel, S., Hier, M., Zeitouni, A., Kost, K., Mlynarek, A., Richardson, K., Black, M., MacDonald, C., et al. (2018) · Psycho-Oncology · doi:10.1002/pon.4889 · Cited by 47
Psychological states in terminal cancer patients as measured over time
Dougherty, K., Templer, D. I., & Brown, R. (1986) · Journal of Counseling Psychology · doi:10.1037/0022-0167.33.3.357 · Cited by 37
Franchini, L., Ercolani, G., Ostan, R., Raccichini, M., Samolsky-Dekel, A., Malerba, M. B., Melis, A., Varani, S., & Pannuti, R. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-019-05155-8 · Cited by 37
Patrick, D. L., Burns, T., Morosini, P., Gagnon, D. D., Rothman, M., & Adriaenssen, I. (2010) · Clinical Therapeutics · doi:10.1016/j.clinthera.2010.02.003 · Cited by 32
Metadata
- Authors
- Schag, C. C., Heinrich, R. L., & Ganz, P. A.
- Venue
- Journal of Clinical Oncology
- Published
- 1984-03
- Volume
- 2
- Issue
- 3
- Pages
- 187-193
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1904205969
- Cited by
- 1,517
- References
- 7
- FWCI
- 4.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.